Item 2.02. Results of Operations and Financial Condition.
On November 9, 2022, Arbutus Biopharma Corporation (the "Company") issued a
press release announcing its financial results for the third quarter ended
September 30, 2022 and certain other information. A copy of the press release is
furnished as Exhibit 99.1 hereto and is incorporated by reference herein.
Item 8.01. Other Events.
On November 9, 2022, the Company posted an updated corporate presentation on its
website at www.arbutusbio.com. A copy of the presentation is filed herewith as
Exhibit 99.2 and is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit Number Description
99.1 Press release dated November 9, 2022
99.2 Corporate Presentation dated November 9, 2022
104 Cover Page Interactive Data File (embedded within the Inline
XBRL document)
© Edgar Online, source Glimpses